Home » Stocks » NUVA

NuVasive, Inc. (NUVA)

Stock Price: $63.95 USD 0.88 (1.40%)
Updated Jul 30, 2021 4:00 PM EDT - Market closed
Market Cap 3.30B
Revenue (ttm) 1.15B
Net Income (ttm) 1.85M
Shares Out 51.57M
EPS (ttm) 0.04
PE Ratio 1,776.39
Forward PE 28.01
Dividend n/a
Dividend Yield n/a
Trading Day July 30
Last Price $63.95
Previous Close $63.07
Change ($) 0.88
Change (%) 1.40%
Day's Open 63.21
Day's Range 63.02 - 64.80
Day's Volume 1,163,043
52-Week Range 43.11 - 72.61

News

Hide News
  • All
  • Videos
  • Press Releases
  • Conversation

NuVasive (NUVA) reports strong segmental and geographical performance driving the top line in second-quarter 2021.

1 day ago - Zacks Investment Research

NuVasive (NUVA) delivered earnings and revenue surprises of 39.54% and 3.03%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?

2 days ago - Zacks Investment Research

SAN DIEGO, July 28, 2021 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrate...

2 days ago - PRNewsWire

The Modulus ALIF 3D-printed porous titanium implant is the latest addition to NuVasive's (NUVA) AMS portfolio for anterior lumbar interbody fusion procedures.

1 week ago - Zacks Investment Research

SAN DIEGO, July 22, 2021 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrate...

1 week ago - PRNewsWire

NuVasive (NUVA) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

1 week ago - Zacks Investment Research

SAN DIEGO, July 14, 2021 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrate...

2 weeks ago - PRNewsWire

We are upbeat about NuVasive's (NUVA) newly-introduced organizational and leadership structure for its global commercial operations as well as its product and services organization.

2 weeks ago - Zacks Investment Research

The FDA informed healthcare providers of potential biocompatibility concerns with NuVasive Inc's (NASDAQ:NUVA) specialized orthopedics' Precice devices. Precice devices are implants for 18 years of age ...

3 weeks ago - Benzinga

SAN DIEGO, June 30, 2021 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrate...

1 month ago - PRNewsWire

NuVasive (NUVA) reported earnings 30 days ago. What's next for the stock?

1 month ago - Zacks Investment Research

SAN DIEGO, May 19, 2021 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated...

2 months ago - PRNewsWire

SAN DIEGO, May 10, 2021 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated...

2 months ago - PRNewsWire

NuVasive's (NUVA) first-quarter revenues improved year over year led by progress in U.S. procedural volumes and international business.

2 months ago - Zacks Investment Research

NuVasive (NUVA) delivered earnings and revenue surprises of 12.12% and 3.88%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?

2 months ago - Zacks Investment Research

SAN DIEGO, May 5, 2021 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated ...

2 months ago - PRNewsWire

NuVasive (NUVA) has moved higher as of late, but there could definitely be trouble on the horizon for this company

2 months ago - Zacks Investment Research

SAN DIEGO, May 3, 2021 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated ...

2 months ago - PRNewsWire

NuVasive (NUVA) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

3 months ago - Zacks Investment Research

Here are five orthopedic device stocks, Integra (IART), Conformis (CFMS), SeaSpine (SPNE), Zimmer Biomet (ZBH), Orthofix (OFIX), which are expected to continue their run over the next few months.

Other stocks mentioned: CFMS, IART, OFIX, SPNE, ZBH
3 months ago - Zacks Investment Research

SAN DIEGO, April 19, 2021 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrat...

3 months ago - PRNewsWire

NuVasive's (NUVA) Simplify Disc demonstrated an overall clinical success rate nearly 10% higher than the anterior cervical discectomy and fusion.

3 months ago - Zacks Investment Research

SAN DIEGO, April 6, 2021 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrate...

3 months ago - PRNewsWire

NuVasive (NUVA) reported earnings 30 days ago. What's next for the stock?

4 months ago - Zacks Investment Research

SAN DIEGO, March 25, 2021 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrat...

4 months ago - PRNewsWire

NuVasive (NUVA) is optimistic about its strong international performance and a huge growth potential in the spine market.

4 months ago - Zacks Investment Research

NuVasive (NUVA) extends its long-term partnership with ISSGF and initiates additional clinical studies to transform the future of spine care.

4 months ago - Zacks Investment Research

NuVasive (NUVA) has moved higher as of late, but there could definitely be trouble on the horizon for this company

4 months ago - Zacks Investment Research

SAN DIEGO, March 16, 2021 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrat...

4 months ago - PRNewsWire

NuVasive (NUVA) expands comprehensive portfolio of C360 with the addition of Simplify Disc.

4 months ago - Zacks Investment Research

NuVasive (NUVA) registers strong international performance in Q4 along with continued adoption of advanced material science implants in the U.S. Spinal Hardware business.

5 months ago - Zacks Investment Research

SAN DIEGO, Feb. 24, 2021 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrate...

5 months ago - PRNewsWire

NuVasive (NUVA) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

5 months ago - Zacks Investment Research

SAN DIEGO, Feb. 8, 2021 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated...

5 months ago - PRNewsWire

SAN DIEGO, Feb. 1, 2021 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated...

5 months ago - PRNewsWire

SAN DIEGO, Jan. 7, 2021 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated...

6 months ago - PRNewsWire

SAN DIEGO, Jan. 5, 2021 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated...

6 months ago - PRNewsWire

SAN DIEGO, Jan. 4, 2021 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated...

6 months ago - PRNewsWire

Investors are optimistic about NuVasive (NUVA) on continued momentum across several recently launched products as well as potential in its U.S. Surgical Support business.

6 months ago - Zacks Investment Research

The ACP system within NuVasive (NUVA) C360 is targeted to reduce common postoperative complications such as dysphagia, malalignment and adjacent level ossification.

7 months ago - Zacks Investment Research

The ACP system within NuVasive's (NUVA) C360 portfolio is targeted to reduce common postoperative complications.

7 months ago - Zacks Investment Research

SAN DIEGO, Nov. 23, 2020 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrate...

8 months ago - PRNewsWire

Out of thousands of stocks that are currently traded on the market, it is difficult to identify those that will really generate strong returns. Hedge funds and institutional investors spend millions of ...

8 months ago - Insider Monkey

SAN DIEGO, Nov. 2, 2020 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated...

8 months ago - PRNewsWire

NuVasive (NUVA) registers strong international performance in Q3 along with several spinal hardware product lines growing at high single digits or more.

8 months ago - Zacks Investment Research

NuVasive, Inc. (NUVA) CEO Chris Barry on Q3 2020 Results - Earnings Call Transcript

9 months ago - Seeking Alpha

NuVasive (NUVA) delivered earnings and revenue surprises of 100.00% and 14.09%, respectively, for the quarter ended September 2020. Do the numbers hold clues to what lies ahead for the stock?

9 months ago - Zacks Investment Research

SAN DIEGO, Oct. 29, 2020 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrate...

9 months ago - PRNewsWire

NuVasive (NUVA) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

9 months ago - Zacks Investment Research

SAN DIEGO, Oct. 19, 2020 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrate...

9 months ago - PRNewsWire

About NUVA

NuVasive, Inc., a medical technology company, develops, manufactures, and sells procedural solutions for spine surgery. it provides surgical access instruments, including Maxcess integrated split-blade retractor system that enable less-invasive surgical techniques by minimizing soft tissue disruption during spine surgery; neuromonitoring systems, which use proprietary software-driven nerve detection and avoidance technology and its intraoperative neuromonitoring services and support; and specialized spinal implants to advance spinal fusion by e... [Read more...]

Industry
Medical Devices
Founded
1997
CEO
J. Christopher Barry
Employees
2,700
Stock Exchange
NASDAQ
Ticker Symbol
NUVA
Full Company Profile

Financial Performance

Financial Statements

Analyst Forecasts

According to 19 analysts, the average rating for NuVasive stock is "Buy." The 12-month stock price forecast is 73.50, which is an increase of 14.93% from the latest price.

Price Target
$73.50
(14.93% upside)
Analyst Consensus: Buy